Developer docs
API playgroundTry for free, no card

Search company profiles

Crystallise

Full company profile

uuid000w17f

Namestring
Crystallise
Legal namestring
Crystallise Ltd
Websiteurl
crystallise.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

Crystallise Ltd is a UK-based, founder-led specialist consultancy founded in 2012 by Dr Chris Martin and Dr Alison Martin, headquartered in Colchester, Essex, and operating as a fully remote business within ±2 hours of UK time. The company conducts multidisciplinary evidence synthesis and biomedical modelling work for the pharmaceutical, healthcare, and insurance/pensions sectors, with a 15-20 person team that combines clinicians, health informaticians, actuaries, and senior systematic reviewers. Its core intellectual property centres on two technology platforms: HEORO, a free, continuously curated database of PubMed-indexed HEOR abstracts tagged by trained NLP classifiers, and Evidence Mapper, a subscription platform for AI-assisted abstract screening, shortlisting, indexing and visualisation that is also used as an in-house service deliverable.

The company's service portfolio spans systematic and targeted literature reviews, rapid evidence synthesis, evidence mapping, global value dossiers, health economic modelling, and network meta-analysis for HTA and market access submissions, alongside mortality, longevity, morbidity, and stochastic SEIR infectious disease modelling for life insurers, reinsurers, annuity providers, and catastrophe modellers. It also offers portfolio data enrichment via synthetic sample generation using Spearman Rank Correlation and Cholesky decomposition, plus horizon scanning, and maintains recurring bulletin products (Longevity Perspectives, Geroscience Focus, HTAngel, Newsflash) that support lead generation.

Commercially, Crystallise operates a hybrid model combining project-based professional services (quote-based, typically enterprise scale), a subscription/SaaS revenue stream from Evidence Mapper, freemium exposure through HEORO, and bulletin subscriptions. It is GDPR compliant, holds a UK Data Protection Act registration, and reaches customers globally through direct sales, content marketing, and a partner ecosystem anchored by a long-standing core relationship with JB Medical and supported by collaborations with Imperial College Health Partners, NHS Midlands and Lancashire CSU, Cogentia, Visible Analytics, Simplified Data, and Terminological.

Short descriptiontext

Crystallise Ltd is a UK-based specialist consultancy that provides multidisciplinary evidence synthesis and mortality/longevity modelling services to pharmaceutical, healthcare, and insurance/pensions clients, supported by the HEORO abstract database and the Evidence Mapper platform.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersColchester, United Kingdom
HQ citystring
Colchester
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
mortality modelling, evidence synthesis services, systematic literature reviews, health economic modelling, longevity risk modelling
Industry4 codes
PRIMARYHLAIALAI
Real-World Evidence (RWE) & HEOR for Development
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
SECONDARYHLAJAJAG
Mortality, Cause-of-Death Coding & Excess Death Analysis
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Statistics, Vital Records & Population Health Analytics
SECONDARYHLAKADAA
Diabetes (General)
SECONDARYHLAGAOAN
Market Access, Pricing & Reimbursement (Evidence Generation) FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Other Scientific and Technical Consulting Services54169
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Evidence Synthesis & Mortality Modelling Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Consulting Services
TypeProfessional Services
Description

Project-based consulting engagements for systematic literature reviews, targeted reviews, rapid evidence synthesis, health economic modelling, mortality and longevity modelling for pharmaceutical, healthcare, insurance and pensions clients. Services include HTA submissions support, market access, and regulatory submissions.

crystallise.com
2Evidence Mapper Subscriptions
TypeSubscription Recurring
Description

Subscription-based access to the Evidence Mapper platform for internal literature review projects. Secure client domains with branded access. Provides recurring revenue from agencies and organisations using the platform independently.

crystallise.com
3HEORO Database
TypeFreemium
Description

Free database platform that generates leads and demonstrates technical capabilities. Not a direct revenue source but supports business development by showcasing indexing and evidence synthesis expertise.

crystallise.com
4Publications and Bulletins
TypeSubscription Recurring
Description

Subscription-based newsletters including Longevity Perspectives, Geroscience Focus bulletins, and HTAngel HTA decisions digest providing recurring engagement with industry professionals.

crystallise.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Personnel, Technology or R&D, Marketing or Sales
Pricing details3 tiers
1Free database access
ModelFreemiumBilling cadenceOthers
Notes

HEORO is described as a 'free database' of abstracts. No pricing tier information available.

crystallise.com
2Evidence Mapper subscriber platform
ModelSubscriptionBilling cadenceNot specified
Notes

New subscriber platform gives agencies and organisations access. Pricing not publicly disclosed; interested parties are directed to email for details.

crystallise.com
3Senior Consultant salary
ModelOtherBilling cadenceAnnual
Notes

Salary range £65,100 – £77,175 for remote working position within ±2 hours of UK time.

crystallise.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 2 records shown
1HEORO
Description

A free database of abstracts of published studies indexed in PubMed relevant to quality of life, costs and resource use and economic evaluations.

crystallise.com
+1 more record
Core offering1 text field

Crystallise conducts multidisciplinary mortality modelling and evidence synthesis for the pharmaceutical, healthcare, insurance and pensions sectors. Its offerings combine professional consulting services (systematic literature reviews, health economic modelling, mortality and longevity modelling, morbidity modelling, infectious disease modelling) with two proprietary technology products: the HEORO free biomedical abstracts database and the Evidence Mapper subscription platform for AI-assisted literature review and screening.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Over 100 scientific literature reviews completed since 2012
+1 more record
Product overview1 text field

Crystallise offers a suite of evidence synthesis and biomedical modelling products and services for the pharmaceutical, healthcare, and insurance/pensions industries. The core products are HEORO (a free database of PubMed-indexed abstracts on health economics and outcomes research) and Evidence Mapper (a platform for systematic literature reviews with AI-assisted screening). The company provides a comprehensive range of consulting services including systematic literature reviews, targeted reviews, rapid evidence synthesis, evidence mapping, global value dossiers, health economic modelling, network meta-analysis, and synthetic sample generation. For the insurance and pensions sector, services include mortality and longevity modelling, morbidity modelling, infectious disease modelling, horizon scanning, and portfolio data enrichment. The company also publishes industry bulletins including Longevity Perspectives, Geroscience Focus, HTAngel (HTA decisions), and Newsflash.

Product and service21 records
1HEORO Database
2Evidence Mapper Platform
CategorySoftware Platform (SaaS)
Description

A subscriber platform providing fast and accurate abstract screening, shortlisting, indexing and visualisation for systematic literature reviews and evidence synthesis. Features an ergonomic screening interface, machine-learning robot-screener software, filtering by country/year/disease subgroup/intervention/methodology/outcome/PRO tools, two-factor authentication, and secure client domains with branded access; available to agencies and organisations running their own literature review projects.

3Pharmaceuticals & Healthcare Consulting
CategoryConsulting Services
Description

Project-based consulting for pharmaceutical and healthcare organisations covering systematic literature reviews, targeted reviews, rapid and micro reviews, evidence mapping, global value dossiers, health economic modelling, network meta-analysis and HTA/market access support.

4Insurance & Pensions Consulting
CategoryConsulting Services
Description

Multidisciplinary consulting for life insurers, reinsurers, bulk annuity providers, pension consultants and catastrophe modellers, covering mortality and longevity modelling, morbidity modelling, infectious disease modelling, portfolio data enrichment and horizon scanning.

5Mortality & Longevity Modelling
CategoryActuarial Modelling Service
Description

Cause-of-death mortality and longevity risk modelling service that combines clinical/epidemiological and actuarial expertise. In-house models incorporate socioeconomic and biomedical risk factors (e.g. smoking, BMI) to support Solvency II internal model parameterisation, longevity risk assessment, mortality improvement projections, and tailored annuity underwriting.

6Infectious Disease Modelling
CategoryActuarial Modelling Service
Description

Pandemic and infectious disease modelling service using an in-house stochastic SEIR model calibrated for US and UK populations. Produces deterministic scenarios, stochastic event sets and Exceedance Probability curves, with the ability to estimate direct and indirect excess mortality for insured lives.

7Morbidity Modelling
CategoryActuarial Modelling Service
Description

Morbidity modelling service delivering advanced pricing and risk assessment tools for disease-specific insurance products, linking high-resolution medical records to morbidity rates.

8Systematic Literature Reviews
CategoryEvidence Synthesis Service
Description

Full systematic literature review service that identifies and assesses all published literature on a topic, with two-researcher abstract screening and full-text data extraction. Used to support regulatory submissions (e.g. NICE HTA) and peer-reviewed journal publications.

9Targeted Literature Reviews
CategoryEvidence Synthesis Service
Description

Targeted literature review service that delivers a broad summary of the most important evidence on a specific research question, screening potentially relevant publications and prioritising high-quality studies with outcomes of greatest interest to the client.

10Rapid Evidence Synthesis
CategoryEvidence Synthesis Service
Description

Rapid and micro evidence synthesis service providing a quick overview of literature at abstract level, with templated slide decks typically delivered within 4-6 weeks to support business development activities.

11Evidence Mapping
CategoryEvidence Synthesis Service
Description

Evidence mapping service that delivers a dynamic summary of the evidence base with filtering and drill-down capabilities, identifying research gaps and providing an overview of the evidence landscape.

12Health Economic Modelling
CategoryHealth Economics Service
Description

Health economic modelling service using a flexible, evidence-based and clinically informed approach for complex diseases and health outcomes, supporting Health Technology Assessments and population-based intervention modelling (e.g. stochastic diabetes model).

13Network Meta-Analysis
CategoryEvidence Synthesis Service
Description

Network meta-analysis service that compares multiple treatments simultaneously using sophisticated statistical analyses, synthesising data from various sources to support strategic decision-making.

14Global Value Dossiers
CategoryMarket Access Service
Description

Comprehensive market access deliverable presenting the evidence supporting the value story for a pharmaceutical product, including slide decks, objection handlers and other leave-pieces for payer engagement.

15Synthetic Sample Generation
CategoryActuarial Modelling Service
Description

Service that uses Spearman Rank Correlation and Cholesky decomposition to create synthetic portfolios that accurately reflect real-world populations, generating samples of 1 million individuals mirroring Health Survey for England characteristics within 0.5% accuracy.

16Portfolio Data Enrichment
CategoryActuarial Modelling Service
Description

Portfolio data enrichment service using sophisticated imputation techniques to estimate portfolio biometrics and risk factor data, enabling insurance clients to enrich their policyholder data for pricing, underwriting and risk assessment.

17Horizon Scanning
CategoryResearch / Intelligence Service
Description

Horizon scanning service that monitors key medical technologies and future developments by quantifying medical progress over time, using data sources including technology patents, biomedical research and clinical trials. Delivered as semi-annual reports covering biomedical research, medical technologies and longevity factors for life insurer portfolio risk management.

18HTAngel HTA Newsletter
CategoryNewsletter / Publication
Description

Monthly free newsletter summarising the latest decisions on new technologies from Health Technology Assessment (HTA) bodies around the world, providing market-access intelligence to pharmaceutical and healthcare subscribers.

19Longevity Perspectives Bulletin
CategoryNewsletter / Publication
Description

Subscription bulletin providing in-depth analysis and insights into factors influencing life expectancy, covering trends, mortality factors and forecasting for the actuarial industry.

20Geroscience Focus Bulletin
CategoryNewsletter / Publication
Description

Subscription bulletin providing accessible yet rigorous overviews of key topics in geroscience that may influence human health and lifespan, targeting insurance industry executives and longevity risk modellers.

21Longevity Newsflash
CategoryNewsletter / Publication
Description

Monthly complimentary digest highlighting newly published peer-reviewed studies and key updates from public health and statistical agencies for the insurance and pensions industry.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Long-standing and close collaborative relationship. JB Medical specializes in health economic modelling and market access support. Companies have worked together on many projects over the years.

Strategic tierSecondaryTypeStrategic or Co-development Partner
Description

Strategic partnership for healthcare innovation and research collaboration.

Strategic tierSecondaryTypeStrategic or Co-development Partner
Description

Collaboration with NHS commissioning support unit for healthcare evidence and modelling projects.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Healthcare consultancy collaboration.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Analytics consultancy partnership.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Large UK actuarial and pensions consultancy with longevity risk modelling capability. Competes for the same life insurance and bulk annuity mortality/longevity work as Crystallise, but as part of a much broader pensions, insurance, and investment practice.

TypeDirect peer
Description

Global HEOR, HTA, and evidence synthesis consultancy (now part of Thermo Fisher/PPD). Direct competitor for Crystallise's pharma systematic review, HTA submission, and market access work, though Evidera operates at much larger scale and global footprint.

TypeEmerging player
Description

UK healthcare analytics consultancy partnered with Crystallise. Smaller peer with overlapping health analytics and evidence capabilities, comparable as a niche UK-based analytics specialist.

TypeDirect peer
Description

Biostatistics and evidence synthesis consultancy providing systematic reviews, real-world evidence, and HTA support to pharma and biotech. Comparable in evidence synthesis and clinical research services though much larger.

TypeEmerging player
Description

UK healthcare consultancy partnered with Crystallise. Comparable as a small UK firm operating in healthcare evidence, market access, and consulting for pharma and NHS clients.

TypeDirect peer
Description

Health economics, outcomes research, and systematic review consultancy now part of Clarivate. Direct competitor in evidence synthesis, HTA submissions, and value dossiers for pharmaceutical clients globally.

TypeDirect peer
Description

University of York spin-out providing HEOR, systematic review, and HTA services to pharma, biotech, and public sector clients. UK-based and directly comparable to Crystallise's pharmaceutical consulting arm.

TypeDirect peer
Description

HEOR and market access consultancy offering systematic literature reviews, HTA submissions, and value communication. Overlaps closely with Crystallise's pharmaceutical evidence synthesis and global value dossier services.

TypeDirect peer
Description

Specialist longevity risk analytics provider serving UK and Canadian pension schemes and insurers. Direct peer for Crystallise's mortality and longevity modelling services targeting the insurance and pensions sector.

TypeDirect peer
Description

UK-based health economic modelling and market access consultancy. Both a strategic partner of Crystallise and a comparable peer, competing for similar HTA and market access work in the UK and Europe.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Crystallise

Evidence Synthesis & Mortality Modelling Servicescrystallise.com

Crystallise Ltd is a UK-based specialist consultancy that provides multidisciplinary evidence synthesis and mortality/longevity modelling services to pharmaceutical, healthcare, and insurance/pensions clients, supported by the HEORO abstract database and the Evidence Mapper platform.

What Crystallise does

Crystallise Ltd is a UK-based, founder-led specialist consultancy founded in 2012 by Dr Chris Martin and Dr Alison Martin, headquartered in Colchester, Essex, and operating as a fully remote business within ±2 hours of UK time. The company conducts multidisciplinary evidence synthesis and biomedical modelling work for the pharmaceutical, healthcare, and insurance/pensions sectors, with a 15-20 person team that combines clinicians, health informaticians, actuaries, and senior systematic reviewers. Its core intellectual property centres on two technology platforms: HEORO, a free, continuously curated database of PubMed-indexed HEOR abstracts tagged by trained NLP classifiers, and Evidence Mapper, a subscription platform for AI-assisted abstract screening, shortlisting, indexing and visualisation that is also used as an in-house service deliverable.

The company's service portfolio spans systematic and targeted literature reviews, rapid evidence synthesis, evidence mapping, global value dossiers, health economic modelling, and network meta-analysis for HTA and market access submissions, alongside mortality, longevity, morbidity, and stochastic SEIR infectious disease modelling for life insurers, reinsurers, annuity providers, and catastrophe modellers. It also offers portfolio data enrichment via synthetic sample generation using Spearman Rank Correlation and Cholesky decomposition, plus horizon scanning, and maintains recurring bulletin products (Longevity Perspectives, Geroscience Focus, HTAngel, Newsflash) that support lead generation.

Commercially, Crystallise operates a hybrid model combining project-based professional services (quote-based, typically enterprise scale), a subscription/SaaS revenue stream from Evidence Mapper, freemium exposure through HEORO, and bulletin subscriptions. It is GDPR compliant, holds a UK Data Protection Act registration, and reaches customers globally through direct sales, content marketing, and a partner ecosystem anchored by a long-standing core relationship with JB Medical and supported by collaborations with Imperial College Health Partners, NHS Midlands and Lancashire CSU, Cogentia, Visible Analytics, Simplified Data, and Terminological.

Crystallise firmographics

Firmographics
Name
Crystallise
Legal name
Crystallise Ltd
Website
https://crystallise.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
11–50 employees
Short description
Crystallise Ltd is a UK-based specialist consultancy that provides multidisciplinary evidence synthesis and mortality/longevity modelling services to pharmaceutical, healthcare, and insurance/pensions clients, supported by the HEORO abstract database and the Evidence Mapper platform.
Ownership category
akta.pro rank

Crystallise industry classification

Industry
Product category
Evidence Synthesis & Mortality Modelling Services
NAICS
Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAIALAI
Real-World Evidence (RWE) & HEOR for Development
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
SECONDARYHLAJAJAG
Mortality, Cause-of-Death Coding & Excess Death Analysis
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Statistics, Vital Records & Population Health Analytics
SECONDARYHLAKADAA
Diabetes (General)
SECONDARYHLAGAOAN
Market Access, Pricing & Reimbursement (Evidence Generation) FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

Keywords

  • Mortality modelling
  • Evidence synthesis services
  • Systematic literature reviews
  • Health economic modelling
  • Longevity risk modelling

Where Crystallise is headquartered

Location

Headquarters

HQ city
Colchester
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Crystallise business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Marketing or Sales

Revenue model

  1. Consulting Services: Project-based consulting engagements for systematic literature reviews, targeted reviews, rapid evidence synthesis, health economic modelling, mortality and longevity modelling for pharmaceutical, healthcare, insurance and pensions clients. Services include HTA submissions support, market access, and regulatory submissions.
  2. Evidence Mapper Subscriptions: Subscription-based access to the Evidence Mapper platform for internal literature review projects. Secure client domains with branded access. Provides recurring revenue from agencies and organisations using the platform independently.
  3. HEORO Database: Free database platform that generates leads and demonstrates technical capabilities. Not a direct revenue source but supports business development by showcasing indexing and evidence synthesis expertise.
  4. Publications and Bulletins: Subscription-based newsletters including Longevity Perspectives, Geroscience Focus bulletins, and HTAngel HTA decisions digest providing recurring engagement with industry professionals.

Pricing tiers

ModelBillingPrice
FreemiumOthersFree database access
SubscriptionNot specifiedEvidence Mapper subscriber platform
OtherAnnualSenior Consultant salary

Go-to-market motion2 records

Distribution channels2 records

Marketing channels8 records

Crystallise product offering

Product offering

Core offering

Crystallise conducts multidisciplinary mortality modelling and evidence synthesis for the pharmaceutical, healthcare, insurance and pensions sectors. Its offerings combine professional consulting services (systematic literature reviews, health economic modelling, mortality and longevity modelling, morbidity modelling, infectious disease modelling) with two proprietary technology products: the HEORO free biomedical abstracts database and the Evidence Mapper subscription platform for AI-assisted literature review and screening.

Product overview

Crystallise offers a suite of evidence synthesis and biomedical modelling products and services for the pharmaceutical, healthcare, and insurance/pensions industries. The core products are HEORO (a free database of PubMed-indexed abstracts on health economics and outcomes research) and Evidence Mapper (a platform for systematic literature reviews with AI-assisted screening). The company provides a comprehensive range of consulting services including systematic literature reviews, targeted reviews, rapid evidence synthesis, evidence mapping, global value dossiers, health economic modelling, network meta-analysis, and synthetic sample generation. For the insurance and pensions sector, services include mortality and longevity modelling, morbidity modelling, infectious disease modelling, horizon scanning, and portfolio data enrichment. The company also publishes industry bulletins including Longevity Perspectives, Geroscience Focus, HTAngel (HTA decisions), and Newsflash.

Differentiator

Problem solved

Functional benefit

Brands

  • HEORO: A free database of abstracts of published studies indexed in PubMed relevant to quality of life, costs and resource use and economic evaluations.
  • Evidence Mapper

Products and services

  • HEORO Database
  • Evidence Mapper Platform A subscriber platform providing fast and accurate abstract screening, shortlisting, indexing and visualisation for systematic literature reviews and evidence synthesis. Features an ergonomic screening interface, machine-learning robot-screener software, filtering by country/year/disease subgroup/intervention/methodology/outcome/PRO tools, two-factor authentication, and secure client domains with branded access; available to agencies and organisations running their own literature review projects.
  • Pharmaceuticals & Healthcare Consulting Project-based consulting for pharmaceutical and healthcare organisations covering systematic literature reviews, targeted reviews, rapid and micro reviews, evidence mapping, global value dossiers, health economic modelling, network meta-analysis and HTA/market access support.
  • Insurance & Pensions Consulting Multidisciplinary consulting for life insurers, reinsurers, bulk annuity providers, pension consultants and catastrophe modellers, covering mortality and longevity modelling, morbidity modelling, infectious disease modelling, portfolio data enrichment and horizon scanning.
  • Mortality & Longevity Modelling Cause-of-death mortality and longevity risk modelling service that combines clinical/epidemiological and actuarial expertise. In-house models incorporate socioeconomic and biomedical risk factors (e.g. smoking, BMI) to support Solvency II internal model parameterisation, longevity risk assessment, mortality improvement projections, and tailored annuity underwriting.
  • Infectious Disease Modelling Pandemic and infectious disease modelling service using an in-house stochastic SEIR model calibrated for US and UK populations. Produces deterministic scenarios, stochastic event sets and Exceedance Probability curves, with the ability to estimate direct and indirect excess mortality for insured lives.
  • Morbidity Modelling Morbidity modelling service delivering advanced pricing and risk assessment tools for disease-specific insurance products, linking high-resolution medical records to morbidity rates.
  • Systematic Literature Reviews Full systematic literature review service that identifies and assesses all published literature on a topic, with two-researcher abstract screening and full-text data extraction. Used to support regulatory submissions (e.g. NICE HTA) and peer-reviewed journal publications.
  • Targeted Literature Reviews Targeted literature review service that delivers a broad summary of the most important evidence on a specific research question, screening potentially relevant publications and prioritising high-quality studies with outcomes of greatest interest to the client.
  • Rapid Evidence Synthesis Rapid and micro evidence synthesis service providing a quick overview of literature at abstract level, with templated slide decks typically delivered within 4-6 weeks to support business development activities.
  • Evidence Mapping Evidence mapping service that delivers a dynamic summary of the evidence base with filtering and drill-down capabilities, identifying research gaps and providing an overview of the evidence landscape.
  • Health Economic Modelling Health economic modelling service using a flexible, evidence-based and clinically informed approach for complex diseases and health outcomes, supporting Health Technology Assessments and population-based intervention modelling (e.g. stochastic diabetes model).
  • Network Meta-Analysis Network meta-analysis service that compares multiple treatments simultaneously using sophisticated statistical analyses, synthesising data from various sources to support strategic decision-making.
  • Global Value Dossiers Comprehensive market access deliverable presenting the evidence supporting the value story for a pharmaceutical product, including slide decks, objection handlers and other leave-pieces for payer engagement.
  • Synthetic Sample Generation Service that uses Spearman Rank Correlation and Cholesky decomposition to create synthetic portfolios that accurately reflect real-world populations, generating samples of 1 million individuals mirroring Health Survey for England characteristics within 0.5% accuracy.
  • Portfolio Data Enrichment Portfolio data enrichment service using sophisticated imputation techniques to estimate portfolio biometrics and risk factor data, enabling insurance clients to enrich their policyholder data for pricing, underwriting and risk assessment.
  • Horizon Scanning Horizon scanning service that monitors key medical technologies and future developments by quantifying medical progress over time, using data sources including technology patents, biomedical research and clinical trials. Delivered as semi-annual reports covering biomedical research, medical technologies and longevity factors for life insurer portfolio risk management.
  • HTAngel HTA Newsletter Monthly free newsletter summarising the latest decisions on new technologies from Health Technology Assessment (HTA) bodies around the world, providing market-access intelligence to pharmaceutical and healthcare subscribers.
  • Longevity Perspectives Bulletin Subscription bulletin providing in-depth analysis and insights into factors influencing life expectancy, covering trends, mortality factors and forecasting for the actuarial industry.
  • Geroscience Focus Bulletin Subscription bulletin providing accessible yet rigorous overviews of key topics in geroscience that may influence human health and lifespan, targeting insurance industry executives and longevity risk modellers.
  • Longevity Newsflash Monthly complimentary digest highlighting newly published peer-reviewed studies and key updates from public health and statistical agencies for the insurance and pensions industry.

Quantifiable outcome

  • Over 100 scientific literature reviews completed since 2012
  • +1 more outcomes

Companies that use Crystallise

Customer profile

Named customers9 records

Segments3 records

Ideal customer profiles4 records

Crystallise technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Crystallise partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core, secondary and minor.

  • JB MedicalcoreStrategic or Co-development PartnerLong-standing and close collaborative relationship. JB Medical specializes in health economic modelling and market access support. Companies have worked together on many projects over the years.
  • Imperial College Health PartnerssecondaryStrategic or Co-development PartnerStrategic partnership for healthcare innovation and research collaboration.
  • NHS Midlands and Lancashire Commissioning Support UnitsecondaryStrategic or Co-development PartnerCollaboration with NHS commissioning support unit for healthcare evidence and modelling projects.
  • CogentiaminorStrategic or Co-development PartnerHealthcare consultancy collaboration.
  • Visible AnalyticsminorStrategic or Co-development PartnerAnalytics consultancy partnership.

Scale indicators3 records

Recent moves5 records

Expansion highlights6 records

Crystallise competitors and assessment

Company assessment

Broad incumbents

  • Hymans Robertson: Large UK actuarial and pensions consultancy with longevity risk modelling capability. Competes for the same life insurance and bulk annuity mortality/longevity work as Crystallise, but as part of a much broader pensions, insurance, and investment practice.

Direct peers

  • Evidera: Global HEOR, HTA, and evidence synthesis consultancy (now part of Thermo Fisher/PPD). Direct competitor for Crystallise's pharma systematic review, HTA submission, and market access work, though Evidera operates at much larger scale and global footprint.
  • Cytel: Biostatistics and evidence synthesis consultancy providing systematic reviews, real-world evidence, and HTA support to pharma and biotech. Comparable in evidence synthesis and clinical research services though much larger.
  • DRG Abacus (Clarivate): Health economics, outcomes research, and systematic review consultancy now part of Clarivate. Direct competitor in evidence synthesis, HTA submissions, and value dossiers for pharmaceutical clients globally.
  • York Health Economics Consortium (YHEC): University of York spin-out providing HEOR, systematic review, and HTA services to pharma, biotech, and public sector clients. UK-based and directly comparable to Crystallise's pharmaceutical consulting arm.
  • Covalence Research: HEOR and market access consultancy offering systematic literature reviews, HTA submissions, and value communication. Overlaps closely with Crystallise's pharmaceutical evidence synthesis and global value dossier services.
  • Club Vita: Specialist longevity risk analytics provider serving UK and Canadian pension schemes and insurers. Direct peer for Crystallise's mortality and longevity modelling services targeting the insurance and pensions sector.
  • JB Medical: UK-based health economic modelling and market access consultancy. Both a strategic partner of Crystallise and a comparable peer, competing for similar HTA and market access work in the UK and Europe.

Emerging players

  • Visible Analytics: UK healthcare analytics consultancy partnered with Crystallise. Smaller peer with overlapping health analytics and evidence capabilities, comparable as a niche UK-based analytics specialist.
  • Cogentia: UK healthcare consultancy partnered with Crystallise. Comparable as a small UK firm operating in healthcare evidence, market access, and consulting for pharma and NHS clients.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Crystallise social profiles

Digital presence

Crystallise compliance and trust

Trust signal

Compliance1 record

Crystallise financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Crystallise leadership team

Management profile

Number of profiles

Profiles7 records

Crystallise funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Crystallise M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Crystallise

What does Crystallise do?

Crystallise conducts multidisciplinary mortality modelling and evidence synthesis for the pharmaceutical, healthcare, insurance and pensions sectors. Its offerings combine professional consulting services (systematic literature reviews, health economic modelling, mortality and longevity modelling, morbidity modelling, infectious disease modelling) with two proprietary technology products: the HEORO free biomedical abstracts database and the Evidence Mapper subscription platform for AI-assisted literature review and screening.

Is Crystallise a public or private company?

Crystallise is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Crystallise founded?

Crystallise was founded in 2012. It employs 11 to 50 people.

Where is Crystallise based?

Crystallise is headquartered in Colchester, United Kingdom, in the Europe region.

How does Crystallise make money?

Four revenue lines are on record. Consulting Services are the primary driver. The others are evidence Mapper Subscriptions, HEORO Database and publications and Bulletins.

Who are Crystallise's main competitors?

Hymans Robertson is listed as a broad incumbent. Direct peers are Evidera, Cytel, DRG Abacus (Clarivate), York Health Economics Consortium (YHEC), Covalence Research, Club Vita and JB Medical. Emerging players are Visible Analytics and Cogentia.

Does Crystallise have an API?

No public API is recorded for Crystallise.

What industry is Crystallise in?

Crystallise's product category is Evidence Synthesis & Mortality Modelling Services. Its primary akta.pro industry code is HLAIALAI, Real-World Evidence (RWE) & HEOR for Development, with a secondary code of HLAJAJAG, Mortality, Cause-of-Death Coding & Excess Death Analysis. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals